STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 65 filers reported holding STOKE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,364 | -97.7% | 600 | -93.7% | 0.00% | – |
| Q2 2023 | $100,645 | +1329.8% | 9,468 | +1020.5% | 0.00% | – |
| Q1 2023 | $7,039 | -26.8% | 845 | -18.9% | 0.00% | – |
| Q4 2022 | $9,618 | -35.9% | 1,042 | -12.7% | 0.00% | – |
| Q3 2022 | $15,000 | -57.1% | 1,194 | -54.6% | 0.00% | – |
| Q2 2022 | $35,000 | -91.9% | 2,628 | -87.2% | 0.00% | – |
| Q1 2022 | $433,000 | -67.1% | 20,560 | -62.5% | 0.00% | -100.0% |
| Q4 2021 | $1,315,000 | +29.7% | 54,794 | +37.4% | 0.00% | 0.0% |
| Q3 2021 | $1,014,000 | -56.1% | 39,867 | -41.9% | 0.00% | 0.0% |
| Q2 2021 | $2,310,000 | +35.3% | 68,616 | +56.2% | 0.00% | 0.0% |
| Q1 2021 | $1,707,000 | +602.5% | 43,937 | +1020.3% | 0.00% | – |
| Q4 2020 | $243,000 | +155.8% | 3,922 | +37.8% | 0.00% | – |
| Q3 2020 | $95,000 | -30.7% | 2,846 | -50.5% | 0.00% | – |
| Q2 2020 | $137,000 | -17.0% | 5,746 | -20.1% | 0.00% | – |
| Q1 2020 | $165,000 | +33.1% | 7,192 | +63.8% | 0.00% | – |
| Q4 2019 | $124,000 | +1277.8% | 4,392 | +979.1% | 0.00% | – |
| Q3 2019 | $9,000 | – | 407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |